Allene M. Diaz, Director at IONIS PHARMACEUTICALS INC (IONS), sold 10,111 shares at $85.42 ($864K) on 2026-07-07, disclosed to the SEC on 2026-07-09.
Scheduled sale ($864k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2024-07-17 | $81K | — | Filing → |
| IONS | SELL | 2023-08-03 | $27K | — | Filing → |